Aprea Therapeutics, Inc. (APRE): SCHEDULE 13G/A filed Apr 27, 2026

Form type

SCHEDULE 13G/A

Filing date

Apr 27, 2026

Accession number

0001493152-26-019073

Filer

Aprea Therapeutics, Inc. (CIK 1781983)